Expedia (EXPE) estimates, target boosted at Credit Suisse. Shares of EXPE now seen reaching $60, according to Credit Suisse. Estimates also upped, given a higher realized conversion rate. Neutral rating.
Fortinet (FTNT) numbers lowered at Jefferies. Shares of FTNT now seen reaching $26, Jefferies said. Estimates also lowered on soft third quarter. Hold rating.
Goldman Sachs (GS) estimates raised at UBS through 2012, UBS said. Focus on capital returns to remain on share buybacks. Neutral rating and $125 price target.
IBM (IBM) estimates, target cut at BMO. IBM estimates were reduced through 2013, BMO Capital said. Company is seeing lower market demand. Market Perform rating and new $218 price target.IBM estimates trimmed at Citigroup. IBM estimates lowered through 2013, Citigroup said. FX headwinds and softer economy. $250 price target and Buy rating. Intel (INTC) numbers cut at UBS. Shares of INTC now seen reaching $29, UBS said. Estimates also lowered on expected lower server processor growth, gross margin. Intel numbers lowered at Jefferies. Shares of INTC now seen reaching $24, Jefferies said. Estimates also lowered on slower growth, lower margins. Hold rating. Kroger (KR) estimates, target raised at Guggenheim. Shares of KR now seen reaching $31, according to Guggenheim. Estimates also increased, given the company's new guidance. Buy rating. PNC Financial (PNC) numbers reduced at BMO. Shares of PNC now seen reaching $68, according to BMO Capital. Estimates also cut, given a lower realized net interest margin. Market Perform rating. PNC Financial Services numbers lowered at Jefferies. Shares of PNC now seen reaching $72, Jefferies said. Estimates also lowered on limited catalysts. Buy rating. Regeneron (REGN) estimates, target raised at BofA/Merrill. Shares of REGN now seen reaching $190, according to Bank of America/Merrill Lynch said. Estimates also increased, given higher expected Eylea growth. Buy rating. UnitedHealth (UNH) estimates, target upped at BMO. UNH estimates were boosted through 2013, BMO Capital said. Company is seeing solid momentum across the board. Outperform rating and new $70 price target. Xerox (XRX) estimates, target increased at BMO. XRX estimates were raised through 2013, BMO Capital said. Company is keeping a tight lid on costs and buying back more stock. Market Perform rating. >To submit a news tip, email: firstname.lastname@example.org.
Twitter and become a fan on Facebook.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV